The CFOs of Pfizer and Moderna have both resigned over the past 72 hours.

Moderna CFO Meline steps down $42 million richer, passing reins to incoming finance chief Gomez.

That’s the current value of his 270,000 stock options—awarded upon his hire in July 2020—which will be fully vested by July 2024. The disclosure came (PDF) in an SEC filing on Monday and Moderna’s 2022 proxy (PDF) statement.

On Monday, Moderna revealed that Meline was stepping down and will be replaced by Jorge Gomez, who leaves his post as CFO at Dentsply Sirona. Gomez, 54, previously served as the finance chief at Cardinal Health.

Gomez will receive a base salary of $700,000, compared with $621,000 for Meline last year. He also receives a $4 million new-hire stock package and annual awards between $3 million and $4 million.

https://www.fiercepharma.com/p....harma/moderna-cfo-me

Pfizer has signed on a new chief financial officer whose dealmaking experience could prove invaluable for the New York pharma as it looks to deploy its COVID-19 vaccine and drug windfall.

David Denton is joining Pfizer as chief financial officer, succeeding company veteran Frank D’Amelio starting May 2, Pfizer said Monday.

Denton was most recently CFO at American home improvement retail giant Lowe’s. But it’s his previous stint in the healthcare industry that drew Pfizer’s attention.

https://www.fiercepharma.com/p....harma/pfizer-signals